Does Extended Use of Clopidogrel-Based Dual Anti-Platelet Therapy Increase the Risk of Gastrointestinal Bleeding?
Gastroenterology Research · 2020 · 13 (4) · 146-149
DOI: 10.14740/gr1285 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gastroenterology Research, 2020. Verfasst von Hafsa Abbas und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Gastroenterology, Bronxcare Health System, Bronx, NY 10457, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Division of Gastroenterology, Bronxcare Health System, Bronx, NY 10457, USA.
- Department of Medicine, Bronxcare Health System, Bronx, NY 10457, USA.
Zitieren
APA
Abbas, H., Kumar Nayudu, S., Ravi, M., Saad, M., Bathini, K., Ravi, P., Roy, S., Arya, D., & Chilimuri, S. (2020). Does Extended Use of Clopidogrel-Based Dual Anti-Platelet Therapy Increase the Risk of Gastrointestinal Bleeding?. Gastroenterology Research, 13(4), 146-149. https://doi.org/10.14740/gr1285
Vancouver
Abbas H, Kumar Nayudu S, Ravi M, Saad M, Bathini K, Ravi P, et al. Does Extended Use of Clopidogrel-Based Dual Anti-Platelet Therapy Increase the Risk of Gastrointestinal Bleeding?. Gastroenterology Research. 2020;13(4):146-149. doi:10.14740/gr1285
BibTeX
@article{Abbas2020,
author = {Abbas, Hafsa and Kumar Nayudu, Suresh and Ravi, Madhavi and Saad, Muhammad and Bathini, Kashyap and Ravi, Pranav and Roy, Swathi and Arya, Divya and Chilimuri, Sridhar},
title = {Does Extended Use of Clopidogrel-Based Dual Anti-Platelet Therapy Increase the Risk of Gastrointestinal Bleeding?},
journal = {Gastroenterology Research},
year = {2020},
volume = {13},
number = {4},
pages = {146--149},
doi = {10.14740/gr1285}
}
EUVIMED